Optimising heart failure pharmacotherapy: the ideal combination.

about

Diuretic usage in heart failure: a continuing conundrum in 2005.The diagnosis and management of cardiac failure.From Adaptation to Maladaptation – An Introduction to the Spectrum of Circulatory Responses in Health and Disease

P2860

Q36056333-7F875F41-6D16-4BB0-BB2C-A239423E18FA Q41112651-52610367-071B-45C6-B4C2-ACF1F43048BC Q58294245-1392697D-C230-43FC-8740-9B5D5C7C86AF

P2860

Optimising heart failure pharmacotherapy: the ideal combination.

Item

http://www.wikidata.org/entity/Q42578735

description

1994 nî lūn-bûn

@nan

1994年の論文

@ja

1994年論文

@yue

1994年論文

@zh-hant

1994年論文

@zh-hk

1994年論文

@zh-mo

1994年論文

@zh-tw

1994年论文

@wuu

1994年论文

@zh

1994年论文

@zh-cn

name

Optimising heart failure pharmacotherapy: the ideal combination.

@en

Optimising heart failure pharmacotherapy: the ideal combination.

@nl

type

Item

label

Optimising heart failure pharmacotherapy: the ideal combination.

@en

Optimising heart failure pharmacotherapy: the ideal combination.

@nl

prefLabel

Optimising heart failure pharmacotherapy: the ideal combination.

@en

Optimising heart failure pharmacotherapy: the ideal combination.

@nl

P1476

Optimising heart failure pharmacotherapy: the ideal combination

@en

P2093

D P Dutka

http://www.w3.org/2001/XMLSchema#string

P2860

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

Predictors of first discharge and subsequent survival in patients with automatic implantable cardioverter-defibrillators.

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

Ancillary diagnostic and therapeutic issues in cardiac failure.

Placebo controlled trial of xamoterol versus digoxin in chronic atrial fibrillation

Lack of effect of nitrates on exercise tolerance in patients with mild to moderate heart failure caused by coronary disease already treated with captopril.

Effect of captopril on functional, physiological and biochemical outcome criteria in aged heart failure patients

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

Beta blockade during and after myocardial infarction: an overview of the randomized trials.

P304

S73-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/HRT.72.2_SUPPL.S73

http://www.w3.org/2001/XMLSchema#string

P433

2 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

John Cleland

P577

1994-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

7946765

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

1025581

http://www.w3.org/2001/XMLSchema#string

Optimising heart failure pharmacotherapy: the ideal combination.

about

P2860

P2860

Optimising heart failure pharmacotherapy: the ideal combination.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932